Clinical Trial Detail

NCT ID NCT03031691
Title A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.

colorectal cancer


Brontictuzumab + Trifluridine

Age Groups: adult senior

No variant requirements are available.